2172 — MicroPort NeuroScientic Balance Sheet
0.000.00%
- HK$5.75bn
- HK$4.69bn
- CNY761.76m
- 66
- 26
- 65
- 53
Annual balance sheet for MicroPort NeuroScientic, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 425 | 593 | 1,135 | 1,018 | 1,036 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 44.5 | 71.7 | 13.4 | 33.9 | 158 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 540 | 784 | 1,285 | 1,333 | 1,370 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 60.3 | 217 | 196 | 164 | 123 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 786 | 1,340 | 1,817 | 1,961 | 2,043 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 94.8 | 174 | 244 | 249 | 262 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 413 | 1,515 | 344 | 325 | 332 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 373 | -175 | 1,473 | 1,636 | 1,711 |
| Total Liabilities & Shareholders' Equity | 786 | 1,340 | 1,817 | 1,961 | 2,043 |
| Total Common Shares Outstanding |